Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders globally. The company is headquartered in San Diego, California.
Click "Analyze" to generate stock analysis
FATE Price Trend and Signals
FATE Option Volumes & Open Interests (aggregated)
FATE Put Call Ratios and IV (aggregated)
FATE Financials
2025-10-27Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.